Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial
Titel:
Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial
Auteur:
Li, J.J. Wang, Z.H. Chen, L. Zhang, W.J. Ma, L.X.X. Wu, J. Liu, G.Y. Hou, Y.F. Yu, K.D. Di, G.H. Fan, L. Jiang, Y.Z. Jiang, S.H. Liang, Q.N. Shen, Y. Shao, Z.-M.